UB Paderborn / Katalog / Suche / in CDI

Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2

The EMBO journal, 2020-09, Vol.39 (18), p.e106275-n/a

2020

Volltextzugriff (PDF)

Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy

Science translational medicine, 2015-03, Vol.7 (279), p.279ra40

2015

Volltextzugriff (PDF)

Viral MLKL Homologs Subvert Necroptotic Cell Death by Sequestering Cellular RIPK3

Cell reports (Cambridge), 2019-09, Vol.28 (13), p.3309-3319.e5

2019

Volltextzugriff (PDF)

Inhibition of Plasmepsin V activity demonstrates its essential role in protein export, PfEMP1 display, and survival of malaria parasites

PLoS biology, 2014-07, Vol.12 (7), p.e1001897-e1001897

2014

Volltextzugriff (PDF)

Mutational profiling of SARS-CoV-2 papain-like protease reveals requirements for function, structure, and drug escape

Nature communications, 2024-07, Vol.15 (1), p.6219-18, Article 6219

2024

Volltextzugriff (PDF)

RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting

Frontiers in cellular and infection microbiology, 2022-12, Vol.12, p.1049065-1049065

2022

Volltextzugriff (PDF)

The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL

Cell death & disease, 2022-04, Vol.13 (4), p.291-291, Article 291

2022

Volltextzugriff (PDF)

Discovery of Potent and Selective Benzothiazole Hydrazone Inhibitors of Bcl‑XL

Journal of medicinal chemistry, 2013-07, Vol.56 (13), p.5514-5540

2013

Volltextzugriff (PDF)

Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro Inhibitors

Frontiers in chemistry, 2022-04, Vol.10, p.861209-861209

2022

Volltextzugriff (PDF)

Oval Cell Numbers in Human Chronic Liver Diseases Are Directly Related to Disease Severity

The American journal of pathology, 1999-02, Vol.154 (2), p.537-541

1999

Volltextzugriff (PDF)

Oval cell-mediated liver regeneration: Role of cytokines and growth factors

Journal of gastroenterology and hepatology, 2003-01, Vol.18 (1), p.4-12

2003

Volltextzugriff (PDF)

Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4

Journal of medicinal chemistry, 2023-03, Vol.66 (5), p.3540-3565

2023

Volltextzugriff (PDF)

Structure activity refinement of phenylsulfonyl piperazines as antimalarials that block erythrocytic invasion

European journal of medicinal chemistry, 2021-03, Vol.214, p.113253, Article 113253

2021

Volltextzugriff (PDF)

The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinase

Biochemical journal, 2023-05, Vol.480 (9), p.665-684

2023

Volltextzugriff (PDF)

A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production

Nature communications, 2015-03, Vol.6 (1), p.6442-6442, Article 6442

2015

Volltextzugriff (PDF)

Optimization of 2‑Anilino 4‑Amino Substituted Quinazolines into Potent Antimalarial Agents with Oral in Vivo Activity

Journal of medicinal chemistry, 2017-02, Vol.60 (3), p.1171-1188

2017

Volltextzugriff (PDF)

Optimisation of 2-(N-phenyl carboxamide) triazolopyrimidine antimalarials with moderate to slow acting erythrocytic stage activity

Bioorganic chemistry, 2021-10, Vol.115, p.105244-105244, Article 105244

2021

Volltextzugriff (PDF)

The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria

ACS medicinal chemistry letters, 2022-11, Vol.13 (11), p.1745-1754

2022

Volltextzugriff (PDF)

Property activity refinement of 2-anilino 4-amino substituted quinazolines as antimalarials with fast acting asexual parasite activity

Bioorganic chemistry, 2021-12, Vol.117, p.105359-105359, Article 105359

2021

Volltextzugriff (PDF)

Exploration of the P3 region of PEXEL peptidomimetics leads to a potent inhibitor of the Plasmodium protease, plasmepsin V

Bioorganic & medicinal chemistry, 2016-05, Vol.24 (9), p.1993-2010

2016

Volltextzugriff (PDF)

Optimization of Benzothiazole and Thiazole Hydrazones as Inhibitors of Schistosome BCL‑2

ACS infectious diseases, 2021-05, Vol.7 (5), p.1143-1163

2021

Volltextzugriff (PDF)

Evaluation of Sca‐1 and c‐Kit As Selective Markers for Muscle Remodelling by Nonhemopoietic Bone Marrow Cells

Stem cells (Dayton, Ohio), 2007-06, Vol.25 (6), p.1364-1374

2007

Volltextzugriff (PDF)

βTrCP- and Rsk1/2-Mediated Degradation of BimEL Inhibits Apoptosis

Molecular cell, 2009-01, Vol.33 (1), p.109-116

2009

Volltextzugriff (PDF)

DNA electroporation in vivo targets mature fibres in dystrophic mdx muscle

Neuromuscular disorders : NMD, 2005-10, Vol.15 (9), p.630-641

2005

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2

Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy

Viral MLKL Homologs Subvert Necroptotic Cell Death by Sequestering Cellular RIPK3

Inhibition of Plasmepsin V activity demonstrates its essential role in protein export, PfEMP1 display, and survival of malaria parasites

Mutational profiling of SARS-CoV-2 papain-like protease reveals requirements for function, structure, and drug escape

RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting

The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL

Discovery of Potent and Selective Benzothiazole Hydrazone Inhibitors of Bcl‑XL

Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro Inhibitors

Oval Cell Numbers in Human Chronic Liver Diseases Are Directly Related to Disease Severity

Oval cell-mediated liver regeneration: Role of cytokines and growth factors

Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4

Structure activity refinement of phenylsulfonyl piperazines as antimalarials that block erythrocytic invasion

The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinase

A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production

Optimization of 2‑Anilino 4‑Amino Substituted Quinazolines into Potent Antimalarial Agents with Oral in Vivo Activity

A small molecule interacts with VDAC2 to block mouse BAK-driven apoptosis

Optimisation of 2-(N-phenyl carboxamide) triazolopyrimidine antimalarials with moderate to slow acting erythrocytic stage activity

The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria

Property activity refinement of 2-anilino 4-amino substituted quinazolines as antimalarials with fast acting asexual parasite activity

Exploration of the P3 region of PEXEL peptidomimetics leads to a potent inhibitor of the Plasmodium protease, plasmepsin V

Optimization of Benzothiazole and Thiazole Hydrazones as Inhibitors of Schistosome BCL‑2

Evaluation of Sca‐1 and c‐Kit As Selective Markers for Muscle Remodelling by Nonhemopoietic Bone Marrow Cells

βTrCP- and Rsk1/2-Mediated Degradation of BimEL Inhibits Apoptosis

DNA electroporation in vivo targets mature fibres in dystrophic mdx muscle

Suchergebnisse filtern